| Ytd | 276.76% | |
| 1y | 136.73% |
| Open | 5.69 | Prev Close | 5.43 | Low | 5.34 | High | 5.89 | Mkt Cap | 51.54M |
| Vol | 45.93K | Avg Vol | 169.24K | EPS | -1.34 | P/E | -3.99 | Forward P/E | -0.89 |
| Beta | 0.84 | Short Ratio | 0.76 | Inst. Own | 12.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 6.27 | 200-d Avg | 5.04 | 1yr Est | 20.50 |
TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage bioph
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Friday